VBI Vaccines Investor Relations Material
Latest events
Fireside Chat
VBI Vaccines
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from VBI Vaccines Inc
Access all reports
VBI Vaccines Inc., also known as Variation Biotechnologies Inc., is a biopharmaceutical company focused on the development and commercialization of vaccines for infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a commercialized hepatitis B vaccine, and has several vaccine candidates in various stages of development. These include treatments for hepatitis B, glioblastoma, cytomegalovirus, and Zika virus, along with multiple coronavirus vaccine candidates. VBI Vaccines has significant collaborations with entities like GlaxoSmithKline, the National Research Council of Canada, and the Coalition for Epidemic Preparedness Innovations. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
The Lego Story: Building a Business Brick by Brick
A detailed account of the most important milestones in the Lego Group's history, as well as an explanation of the philosophy guiding the company
2 May 2024
Kevin Plank and the Rise of Under Armour
Dive into the story of Under Armour and its founder Kevin Plank, highlighting both successes and mistakes.
30 Apr 2024
Ticker symbol
Country
🇺🇸 United States